Added to YB: 2019-02-07
Pitch date: 2019-02-07
SCYX:US [bullish]
SCYNEXIS, Inc.
-95.82%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States.
Market Cap
$48.2M
Pitch Price
$93.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.18
P/E
-3.64
EV/Sales
-0.21
Sector
Pharmaceuticals
Category
N/A
Show full summary:
SCYNEXIS INC COM SCYX:US
A summary for this pitch has not been created yet.
Read full article (0 min)